China NT Pharma Group Company Limited

HK$0.24As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1011Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (34.63%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) (2.00)
PE TTM —
TSR TTM (68.72%)
Mkt cap HK$231.6M
ROIC (5.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.255
4.54%
(55.85%)
Hold 0|3|3|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
16.36%
29.46%
15.58%
10.97%
Revenue¥M
12.25
12.21
12.67
12.93
10.67%
6.23%
5.29%
5.24%
Peers (US$29.54M)
Cap (US$)
PE
35.84M
4.009x
Capital
TTM
5Y
10Y
Leveragex
8.853
0.072
0.046
EBIT/Intx
7.289
0.206
0.205
Own earn%
88.06
128.76
75.64
Sh yield%
32.39
34.16
35.65
Owners
Insiders/Inst%
4.05
55.94
Short interest%
4.27
SBC / revenue%
0.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
7–14
$1 testx
0.1
Incr. ROIC%
6